Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Buckner

Showing results (171-180 of 255) with videos related to

Pageof 26
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase II trial of primary chemotherapy followed by reduced-dose radiation for CNS germ cell tumorsJ C Buckner, P P Peethambaram, W A Smithson, et al.
Investigational New Drugs|September 1, 2005
Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: a North Central Cancer Treatment Group trialEvanthia Galanis, Jan C Buckner, Matthew J Maurer, et al.
International Journal of Radiation Oncology, Biology, Physics|April 22, 2006
Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: results of North Central Cancer Treatment Group protocol N0177Sunil Krishnan, Paul D Brown, Karla V Ballman, et al.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2011
Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51Thomas B Daniels, Paul D Brown, Sara J Felten, et al.
Journal of Neuro-Oncology|July 5, 2014
The impact of concurrent temozolomide with adjuvant radiation and IDH mutation status among patients with anaplastic astrocytomaSani H Kizilbash, Caterina Giannini, Jesse S Voss, et al.
Investigational New Drugs|August 25, 2000
A North Central Cancer Treatment Group phase II trial of topotecan in relapsed gliomasP A Burch, A M Bernath, T L Cascino, et al.
Journal of Neurosurgery|November 4, 2008
Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trialEdward G Shaw, Brian Berkey, Stephen W Coons, et al.
Neuro-Oncology|September 20, 2013
New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trialsThierry Gorlia, Wenting Wu, Meihua Wang, et al.
Neuro-Oncology|June 27, 2002
Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomasHiroko Kuriyama, Kathleen R Lamborn, Judith R O'Fallon, et al.
Mbio|April 26, 2018
Clinically Relevant Plasmid-Host Interactions Indicate that Transcriptional and Not Genomic Modifications Ameliorate Fitness Costs of <i>Klebsiella pneumoniae</i> Carbapenemase-Carrying PlasmidsMichelle M C Buckner, Howard T H Saw, Rachael N Osagie, et al.
Pageof 26

Showing results (171-180 of 255) with videos related to

Sort By:
Pageof 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase II trial of primary chemotherapy followed by reduced-dose radiation for CNS germ cell tumorsJ C Buckner, P P Peethambaram, W A Smithson, et al.
Investigational New Drugs|September 1, 2005
Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: a North Central Cancer Treatment Group trialEvanthia Galanis, Jan C Buckner, Matthew J Maurer, et al.
International Journal of Radiation Oncology, Biology, Physics|April 22, 2006
Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: results of North Central Cancer Treatment Group protocol N0177Sunil Krishnan, Paul D Brown, Karla V Ballman, et al.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2011
Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51Thomas B Daniels, Paul D Brown, Sara J Felten, et al.
Journal of Neuro-Oncology|July 5, 2014
The impact of concurrent temozolomide with adjuvant radiation and IDH mutation status among patients with anaplastic astrocytomaSani H Kizilbash, Caterina Giannini, Jesse S Voss, et al.
Investigational New Drugs|August 25, 2000
A North Central Cancer Treatment Group phase II trial of topotecan in relapsed gliomasP A Burch, A M Bernath, T L Cascino, et al.
Journal of Neurosurgery|November 4, 2008
Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trialEdward G Shaw, Brian Berkey, Stephen W Coons, et al.
Neuro-Oncology|September 20, 2013
New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trialsThierry Gorlia, Wenting Wu, Meihua Wang, et al.
Neuro-Oncology|June 27, 2002
Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomasHiroko Kuriyama, Kathleen R Lamborn, Judith R O'Fallon, et al.
Mbio|April 26, 2018
Clinically Relevant Plasmid-Host Interactions Indicate that Transcriptional and Not Genomic Modifications Ameliorate Fitness Costs of <i>Klebsiella pneumoniae</i> Carbapenemase-Carrying PlasmidsMichelle M C Buckner, Howard T H Saw, Rachael N Osagie, et al.
Pageof 26